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Abstract
Background: Neonates with hypoxic ischaemic encephalopathy (HIE) are routinely treated with therapeutic
hypothermia (TH) for 72 h in order to improve neurological outcome. Subcutaneous fat necrosis (SCFN) is an
adverse event occurring in neonates with HIE.
Methods: We analyzed risk factors for SCFN regarding demographic factors, cooling methods and deviation from
target temperature range during hypothermia therapy. Data of all neonates registered in the National Asphyxia and
Cooling Register in Switzerland between 2011 and 2013 were analyzed.
Results: 2.8 % of all cooled neonates with HIE developed SCFN. Perinatal and neonatal characteristics did not differ
between neonates with and without SCFN. Applied cooling methods did not correlate with the occurrence of
SCFN. In neonates with SCFN 83.3 % of all noted temperatures were within the target temperature range versus
77.5 % in neonates without SCFN. Neonates with SCFN showed 3.6 % of all measured temperatures below target
temperature range compared to 12.7 % in neonates without SCFN.
Conclusion: Subcutaneous fat necrosis in the neonate with HIE undergoing TH is a potential adverse event that
seems to occur independently from the whole-body cooling method applied and proportion of temperature
measurements outside target temperature range. In this cohort, moderate overcooling associated with moderate
hypothermia (33.0–34.0 °C) does not seem to be an independent risk factor for SCFN. There is no correlation
between the severity of HIE and incidence of SCFN.
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Background
Therapeutic Hypothermia (TH) improves survival and
neurodevelopment in neonates with moderate to severe
hypoxic ischaemic encephalopathy (HIE) [1–4]. No
major complications are associated with therapeutic
hypothermia [3, 5]. However, in recent years, several
cases of neonates with HIE suffering from subcutaneous
fat necrosis (SCFN) have been reported in cooled [1, 6]
and non cooled neonates [7, 8]. Whether SCFN is due
to the primary insult of hypoxia/ischaemia or to the ex-
posure to cold temperature or a combination of both
still needs to be evaluated. Recent data suggest that TH
could be an additional risk factor for SCFN in neonates
with HIE [1, 6] although SCFN is also described in the
pre cooling era. SCFN is characterized by firm palpable
nodules or plaques with or without erythema appearing
within the first weeks of life. SCFN is rare but may result
in complications such as hypoglycemia, hypertri-
glyceridemia, thrombocytopenia and sometimes life-
threatening hypercalcemia. The pathogenesis of these
complications is not fully understood. It is partly as-
sociated with the perinatal ischemia/hypoxemia itself
and with the resolution of the skin lesions with ac-
companying endocrinological changes. SCFN is self-
healing, sometimes with residua such as skin atrophy
and scarring [7, 9, 10].
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The aim of this study is (i) to compare perinatal and
neonatal characteristics of neonates with and without
SCFN registered in the Swiss National Asphyxia and
Cooling Register, (ii) to identify risk factors for SCFN
and (iii) to evaluate cooling management and different
cooling methods with regard to the development of
SCFN.
Methods
A National Asphyxia and Cooling Register was intro-
duced in Switzerland in 2011. All nine Swiss tertiary
level neonatal intensive care units and two paediatric in-
tensive care units are part of the register. The conduc-
tion of the register including data collection, data
analysis and data publication has been approved by the
federal committee of experts on professional secret in
medical research (“Eidgenoessische Expertenkommission
fuer das Berufsgeheimnis in der medizinischen For-
schung”). There is no need for parental consent, because
the register is anonymous. A questionnaire for each neo-
nate with registered SCFN was sent retrospectively to
the centers (Additional file 1).
Neonates with hypoxic ischaemic encephalopathy
cooled or not cooled were registered. Newborn infants
were cooled according to a register cooling protocol
[5]. The register documents are available online (http://
www.neonet.unibe.ch/php/manuel.php?locator=tab-
s4acc2). Neonates undergoing therapeutic hypothermia
were cooled for 72 h with a target temperature range of
33.0–34.0 °C followed by a rewarming period (rewarm-
ing 0.2–0.5 °C per hour). All centers used whole-body
cooling, but different cooling methods were applied.
We grouped the different cooling methods into three
categories: active cooling (with cooling device; Blanke-
trol III (Cincinnati Sub-Zero Products, Inc., Cincinnati,
OH, USA) (n = 1 unit, n = 8 neonates), the CritiCoolTM
(MTRE, Charter Kontrom, Milton Keynes, UK) (n = 3
units, n = 35 neonates), Allon system (MTRE Charter
Kontrom, Milton Keynes, UK) (n = 1 unit, n = 1 neo-
nate), Arctic sun (Bard Medical S.A., Oberrieden,
Switzerland) (n = 1unit, n = 7 neonates), passive cooling
(natural cooling, neonate undressed, no external heat-
ing, n = 4 units, n = 33 neonates) and passive cooling in
combination with gel or ice packs (n = 5 units, n = 44
neonates) in addition to natural cooling. All neonates
had their core temperature monitored with either rectal
or oesophageal probes.
All investigations including blood sampling and neu-
romonitoring was according to our register protocol
(http://www.neonet.unibe.ch/php/manuel.php?locator=
tabs4acc2).
Daily clinical examination reveals the diagnosis of
SCFN during hospitalisation. After discharge all neo-
nates with hypoxic ischaemic encephalopathy were
followed by a paediatrician at least one week after dis-
charge, at the age of one, two and four months.
Statistics
Data are presented as frequencies and medians with
ranges. Significant differences of perinatal/neonatal char-
acteristics and cooling data between the group with and
the group without SCFN were assessed using Mann–
Whitney test and Pearson’s chi-squared test as appropri-
ate. Statistical significance was defined as a p-value of
less than 0.05. Statistical analyses were performed using
SPSS software (Statistical Package for the Social Sciences,
Version 20; SSPS Inc., ChicagoIllinois, USA).
Results
Patients
201 neonates with HIE (cooled and non-cooled) were
registered between 2011 and 2013. Patient recruitment
is depicted in Fig. 1. Fourteen neonates died, none of
them developed subcutaneous fat necrosis before death.
All neonates who were not cooled had a mild HIE (de-
fined by Sarnat stage 1 or Thompson stage <7) [11, 12],
but did not meet cooling criteria. None exceeded the
time window for initiation of therapy.
The incidence of subcutaneous fat necrosis in our
study population was 2.8 % (4/142) of all cooled neo-
nates and 3.2 % (4/127) of neonates with a full course of
therapeutic hypothermia (TH for 72 h). No SCFN oc-
curred or was reported in non-cooled neonates and in
neonates cooled for less than 72 h. Two cooled neonates
with SCFN were treated in the same center (incidence of
SCFN for this center is 2/29 neonates (6.9 %)) whereas
the remaining two cooled neonates with SCFN were
treated in different centers (incidence of SCFN per cen-
ter is 1/16 neonates (6.3 %) and 1/12 neonates (8.3 %),
respectively). No neonate developed SCFN in the other
7 centers.
There were no statistically significant differences be-
tween the two groups (with and without SCFN) regarding
perinatal and neonatal characteristics including gestational
age, Sarnat and Thompson Scores (Table 1) [11, 12].
The four neonates developing SCFN (two inborns, two
outborns) were born after an uneventful pregnancy. None
of the mothers had known maternal risk factors for the
occurrence of SCFN such as diabetes mellitus/gestational
diabetes, hypertension, preeclampsia, seizures, thyroid
dysfunction or illicit drug consumption [7, 8, 10]. None of
the neonates had known risk factors such as meconium
aspiration or macrosomia [7, 8, 10]. Demographic details
of the four neonates with SCFN are shown in Table 2.
Cooling
Those neonates who were cooled less than 72 h were ex-
cluded from further analysis. All included neonates were
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Fig. 1 Flowchart patient recruitment. 201 neonates with HIE were registered between 2011 and 2013. Data of 17 neonates were incomplete and 42
neonates did not fulfill the cooling criteria. 142 neonates underwent therapeutic hypothermia, 128 of them underwent a full course (72 h hypothermia
therapy followed by rewarming period). Four cooled neonates developed SCFN. *16 neonates with missing data concerning subcutaneous fat necrosis
(SCFN). +one neonate was registered with SCFN, but in the notes no SCFN was mentioned. HIE hypoxic ischaemic encephalopathy SCFN
subcutaneous fat necrosis
Table 1 Perinatal and neonatal characteristics of all cooled neonates with HIE (n = 142)
With SCFN (n = 4) Without SCFN (n = 138) p-value
Gestational age [days] 278 [268–301] 279 [244–302] ns
Birth weight [grams] 3340 [3190–3920] 3200 [1790–4700] ns
Head circumference [cm] 34.75 [34.0–35.5] 34.50 [30.5–40.0] ns
APGAR score 5 min 4 [1–7] 3 [0–10] ns
APGAR score 10 min 7 [4–8] 5 [0–10] ns
Umbilical artery pH 6.96 [6.90–7.05] 6.92 [6.54–7.43] ns
Worst pHa 7.02 [6.90–7.19] 6.88 [6.50–7.46] ns
Worst lactate[mmol/l][mmol/l]a 18 [15.0–19.0] 15 [1.80–28.0] ns
Sarnat Score on admission 1.5 [1.0–2.0] 2.0 [1.0–3.0] ns
Thompson Score on admission 4.5 [3.0–6.0] 9.0 [2.0–15.0] ns
Sarnat Score after TH 1.0 [1.0–1.0] 1.0 [1.0–3.0] ns
Thompson Score after TH 1.0 [1.0–1.0] 3.0 [1.0–17.0] 0.05
All values given as median and range [in parenthesis]
SCFN subcutaneous fat necrosis, TH therapeutic hypothermia, ns not significant
aworst pH and worst lactate within first 60 min of life
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cooled for 72 h and developed no severe complications
of TH including severe coagulopathy, thrombocytopenia,
pulmonary hypertension or infection.
50/127neonates (39.4 %) were actively cooled, 33/127
neonates (26.0 %) passively, and 44/127 neonates (34.6 %)
passively in combination with gel/ice packs. In all neo-
nates undergoing TH temperature was monitored every
hour. The cooling methods did not significantly influence
the percentage of temperature measurements in target
temperature range (passive cooling 73.3 %, passive with
additional ice/gel packs 79.5 %, active 78.9 %, p = 0.35),
Fig. 2).
The incidence of SCFN with passive cooling in com-
bination with gel/ice packs is 4.5 % (2/44 neonates), with
active cooling 4 % (2/50 neonates) and no SCFN was
noted in the neonates passively cooled. Data shown sug-
gests that active cooling and application of ice/gel packs
could be a risk factor for SCFN, but SCFN occurred in-
dependently from the cooling method (Pearson chi-
squared test p = 0.223). Seventy percent of all actively
cooled neonates were treated with the Criticool system,
therefore it might not be surprising that the two neo-
nates which had SCFN in the actively cooled group were
treated with the Criticool system.
Of all noted temperatures 83.3 % were within the tar-
get temperature range (33.0–34.0 °C) in neonates with
SCFN versus 77.5 % in neonates without SCFN. Thirteen
percent of the temperature values were above 34.0 °C in
the group with SCFN versus 9.7 % in neonates without
SCFN. Neonates with SCFN showed 3.6 % of all mea-
sured temperatures below the target temperature range
compared to 12.7 % in neonates without SCFN. SCFN
occurred independently of the percentage of measured
temperatures within target temperature range (within/
below/above, Pearson chi-squared test p = 0.199)
Discussion
In our study population the incidence of SCFN in cooled
neonates with HIE was 2.8 % which is consistent with
previous reports [6, 9]. Overlooking the past forty years,
approximately 20 articles (mostly case reports) have
been published on SCFN occurring in context with HIE
in neonates (Additional file 2: Table S1). Most of the
studies investigated non cooled neonates with HIE and
SCFN.
Certain maternal risk factors such as maternal diabetes
mellitus, hypertension, preeclampsia, seizures, thyroid
dysfunction or illicit drug consumption have been men-
tioned in the literature [7, 8, 10]. None of them were
found in our study population nor could we find the
known neonatal risk factors such as meconium aspiration,
hypoglycemia or macrosomia [7, 8, 10]. In our study none
Table 2 Characteristics of all 4 neonates with SCFN
SCFN Case 1 Case 2 Case 3 Case 4
Sex Female Female Male Female
Gestationalage[weeks] 38 2/7 40 2/7 39 1/7 40 0/7
Birth weight [grams] 3920 3480 3400 3190
Mode of delivery Emergency caesarian section Instrumental delivery Instrumental delivery Emergency caesarian section
Age at appearance of SCFN
[days]
16 3 6 4
Cooling method applied Passive plus ice packs Passive plus ice packs Active (Criticool System) Active (Criticool System)
Localization of SCFN Left scapula region and dorsal
upper arm
Back Back Upper back
Appearance of SCFN Red nodules, plaques Red nodules, plaques Palpablenodules,
plaques
Red nodules, plaques
Diagnosis by Neonatologist Neonatologist Neonatologist Neonatologist
Therapy Conservative Conservative Conservative Hydration, low calcium formula,
no vitamin D supplementation,
analgesia
Thrombocytopenia No No No No
Hypoglycemia No No No No
Calcium level ionized (total)
[mmol/l]
1.41 (2.49) 1.33 1.5 1.54 (2.77)
Follow-up Yes Yes Yes Yes
Who Pediatrician, pediatric surgeon Pediatrician Pediatrician Pediatrician, endocrinologist
Examination Clinical follow-up Clinical follow-up and
calcium level
Clinical follow-up Clinical follow-up, calcium level
and ultrasound of kidneys
SCFN subcutaneous fat necrosis calcium level: routinely ionized calcium is measured
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of the analyzed perinatal and neonatal characteristics
showed statistical significance between neonates with and
without SCFN (Table 1). We may have been unable to
confirm the risk factors described by Mahé et al. and
Burden et al., as they analyzed non-cooled neonates in
contrast to our neonates who underwent TH [7, 8].
Additionally our sample size might be too small to de-
tect an association of the known risk factors.
In line with the proposed pathophysiology of SCFN
one might expect SCFN to occur in neonates with more
severe HIE independently of cooling. However, in our
study population there was no significant difference of
the Sarnat and Thompson Score, Apgar Score or meta-
bolic parameters within the first hour of life between
both groups [11, 12].
Certain body areas with bony protuberances are most
susceptible to SCFN [10, 13], namely the back and the
occipital scalp as seen on Additional file 3: Figure S1
(parental consent was obtained to publish this picture).
This is also true in our collective and the question arises
whether the occurrence of SCFN correlates to the cool-
ing technique applied. However, our data does not show
any association between applied cooling method and the
incidence of SCFN. It seems to be a coincidence that no
SCFN occurred in the group of passively cooled neo-
nates with HIE.
Nevertheless, as in our study population most neo-
nates with HIE are bedded in supine position with SCFN
occurring on the back, regular changing of position is
advocated to reduce any damage. Regular mobilization
should be routinely integrated in the nursing protocol, if
the neonate is stable enough [9, 14].
Our findings support the data of the TOBY Register
that moderate hypothermia during 72 h could be an
additional risk factor for SCFN, although our sample
size is quite small and we investigated only 42 non
cooled neonates as a control group [6]. This does not
mean that SCFN does not appear in non-cooled neo-
nates with HIE, because birth asphyxia is a risk factor
per se.
Of interest, SCFN occurred independently of the per-
centage of measured temperatures within the target
temperature range during TH. Compared to the find-
ings that severe hypothermia (core temperature below
28.0 °C) is a described risk factor for developing SCFN
[15], overcooling below 33.0 °C (but above 31.5 °C) did
not emerge as a risk factor in our study population.
SCFN can still occur after discharge from hospital.
This is one of the reasons why SCFN might be well
unrecognized and thus undiagnosed. Therefore, it is im-
portant to inform the parents and the outpatient paedia-
tricians of the nature of SCFN.
Fig. 2 Boxplots of body temperature of cooled neonates over time. Passive cooling (n = 33), passive cooling with gel/ice packs (n = 44), Criticool
system (n = 35), Blanketrol III, Arctic Sun and Allon system (n = 15)
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Limitations
As we analyzed the data of the National Asphyxia and
Cooling Register we describe the incidence of SCFN dur-
ing hospitalization. After discharge all neonates were
regularly followed by an outpatient paediatrician one
week after discharge, at the age of one, two and four
months. However they are not followed by the initial
care takers.
Numbers of SCFN in our study population are small
and conclusions are difficult to draw. Firm conclusions
cannot be supported by this data, but they show a
tendency.
Furthermore the SCFN were evaluated with a retro-
spective questionnaire which entails certain limita-
tions. In the future as soon as SCFN is diagnosed a real
time questionnaire needs to be obtained. A national
register therefore permits to follow a trend and is im-
portant to discover adverse events and to improve pa-
tient management.
Conclusion
Subcutaneous fat necrosis of neonates with HIE under-
going TH is an adverse event that seems to occur inde-
pendently from the severity of HIE, the cooling method
applied and the proportion of measured temperatures
outside target temperature range. In this cohort moder-
ate overcooling associated with moderate hypothermia
(33–34 °C) does not seem to be a risk factor for SCFN.
Additional files
Additional file 1: Questionnaire for subcutaneous fat necrosis
(SCFN).
Additional file 2: Table S1. Published studies of SCFN in neonates
with HIE [16–23].
Additional file 3: Neonate with HIE and SCFN.
Abbreviations
SCFN: Subcutaneous fat necrosis; TH: Therapeutic hypothermia; HIE: Hypoxic
ischaemic encephalopathy; Ns: Not significant.
Competing interests
None of the authors has a conflict of interest to declare.
Authors’ contributions
BG initially analyzed data and drafted the initial manuscript and approved
the final manuscript as submitted. LW critically reviewed the manuscript and
approved the final manuscript as submitted. CH collected data and critically
reviewed the manuscript and approved the final manuscript as submitted.
BB designed the study, supervised data collection, reviewed and revised the
manuscript and approved the final manuscript as submitted. All authors read
and approved the final manuscript.
Acknowledgement
None of the authors has an acknowledgement to declare
Funding
BB is funded by the career program “Filling the Gap” University Zurich, CH
was funded by UNESCO, Swiss Academics for Art and Science and L’Oréal
(Science for Women)
The National Asphyxia and cooling Register group: Aarau: Cantonal Hospital
Aarau, Children’s Clinic, Department of Neonatology (Ph. Meyer, T. Voelker);
Basel: University Children's Hospital Basel (UKBB), Department of
Neonatology (S.M. Schulzke, S. Wellmann); Berne: University Hospital Berne,
Department of Paediatric Intensive care (B. Wagner, K. Daetwyler, M. Nelle);
Chur: Children’s Hospital Chur, Department of Neonatology (W. Baer,
B.Scharrer); Lausanne: University Hospital (CHUV), Department of
Neonatology (J.-F. Tolsa, A. Truttmann, J. Schneider); Geneva: University
Hospital (HUG), Division of Neonatology (R. E. Pfister); Lucerne: Children’s
Hospital of Lucerne, Neonatal and Paediatric Intensive Care Unit (T. M.
Berger, M. Fontana); St. Gallen: Children’s Hospital St. Gallen, Neonatal and
Paediatric Intensive Care Unit (J. P. Micallef, I. Hoignè); Zurich: University
Hospital of Zurich (USZ), Department of Neonatology (HU. Bucher, G.
Natalucci, M. Adams); and University Children’s Hospital Zurich, Department
of Intensive Care and Neonatology (B. Frey)
Author details
1Department of Paediatric and Neonatal Intensive Care, University Children’s
Hospital Zurich, Steinwiesstrasse 75, 8032 Zurich, Switzerland. 2Department of
Paediatric Dermatology, University Children’s Hospital Zurich, Steinwiesstrasse
75, 8032 Zurich, Switzerland. 3Department of Dermatology, University
Hospital Zurich, 8091 Zurich, Switzerland. 4Clinic ofNeonatology, University
Hospital Zurich, Frauenklinikstrasse 10, 8091 Zurich, Switzerland.
Received: 28 January 2015 Accepted: 26 June 2015
References
1. Shankaran S, Laptook A, Ehrenkranz R, Tyson J, Donovan E. Whole-body
hypothermia for neonates with hypoxic–ischemic encephalopathy. N Engl J
Med. 2005;353(15):1574–84.
2. Azzopardi D, Strohm B, Marlow N, Brocklehurst B, Deierl A, Eddama O, et al.
Effects of hypothermia for perinatal asphyxia on childhood outcomes.
N Engl J Med. 2014;371(2):140–9.
3. Jacobs SE, Berg M, Hunt R, Tarnow-Mordi WO, Inder TE, Davis PG. Cooling
for newborns with hypoxic ischaemic encephalopathy. Cochrane Database
of Syst Rev. 2013;1:CD003311.
4. Tagin MA, Woolcott CG, Vincer MJ, Whyte RK, Stinson DA. Hypothermia for
neonatal hypoxic ischemic encephalopathy: an updated systematic review
and meta-analysis. Arch Pediatr Adolesc Med. 2012;166(6):558–66.
5. Azzopardi DV, Strohm B, Edwards AD, Dyet L, Halliday HL, Juszczak E, et al.
Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J
Med. 2009;361(14):1349–58.
6. Strohm B, Hobson A, Brocklehurst P, Edwards AD, Azzopardi D, UK TOBY
Cooling Register. Subcutaneous fat necrosis after moderate therapeutic
hypothermia in neonates. Pediatrics. 2011;128(2):e450–452.
7. Mahé E, Girszyn N, Hadj-Rabia S, Bodemer C, Hamel-Teillac D, De Prost Y.
Subcutaneous fat necrosis of the newborn: a systematic evaluation of risk
factors, clinical manifestations, complications and outcome of 16 children.
Br J Dermatol. 2007;156(4):709–15.
8. Burden AD, Krafchik BR. Subcutaneous fat necrosis of the newborn: a review
of 11 cases. Pediatric Dermatol. 1999;16(5):384–7.
9. Filippi L, Catarzi S, Padrini L, Fiorini P, la Marca G, Guerrini R, et al. Strategies
for reducing the incidence of skin complications in newborns treated with
whole-body hypothermia. J Matern Fetal Neonatal Med. 2012;25(10):2115–21.
10. Oza V, Treat J, Cook N, Tetzlaff MT, Yan A. Subcutaneous fat necrosis as a
complication of whole-body cooling for birth asphyxia. Arch Dermatol.
2010;146(8):882–5.
11. Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress. A
clinical and electroencephalographic study. Arch Neurol. 1976;33(10):696–705.
12. Thompson CM, Puterman AS, Linley LL, Hann FM, van der Elst CW, Molteno
CD, et al. The value of a scoring system for hypoxic ischaemic
encephalopathy in predicting neurodevelopmental outcome. Acta Pediatr.
1997;86(7):757–61.
13. Hogeling M, Meddles K, Berk DR, Bruckner AL, Shimotake TK, Cohen RS,
et al. Extensive Subcutaneous Fat Necrosis of the Newborn Associated with
Therapeutic Hypothermia. Pediatr Dermatol. 2012;29(1):59–63.
14. Calisici E, Oncel MY, Degirmencioglu, Sandal G, Canpolat FE, Erdeve O, et al.
A neonate with subcutaneous fat necrosis after passive cooling: does
polycythemia have an effect? Case Rep Pediatr. 2013;2013:254089.
doi:10.1155/2013/254089.
Grass et al. BMC Pediatrics  (2015) 15:73 Page 6 of 7
15. Atherton DJ, Gennery AR, Cant AJ. The Neonate. In: Burns T, Breathnach S,
Cox N, Griffiths C, editors. Rook’s Textbook of Dermatology. Massachusetts,
USA: Blackwell; 2004.
16. Kuboi T, Kusaka T, Okazaki K, Kaku U, Kakinuma R, Kondo M, et al.
Subcutaneous fat necrosis after selective head cooling in an infant. Pediatr
Int. 2013;55(2):e23–4.
17. Woods AG, Cederholm CK. Subcutaneous fat necrosis and whole-body
cooling therapy for neonatal encephalopathy. Adv Neonatal Care.
2012;12(6):345–8.
18. Zifman E, Mouler M, Eliakim A, Nemet D, Pomeranz A. Subcutaneous fat
necrosis and hypercalcemia following therapeutic hypothermia—a patient
report and review of the literature. J Pediatr Endocrinol Metab.
2010;23(11):1185–8.
19. Ghergherehchi R. Complication of subcutaneous fat necrosis of the
newborn: a case report and review of the literature research. J Biol Sci.
2008;3(9):1004–7.
20. Aucharaz KS, Baker EL, Millman GC, Ball RJ. Neonatal subcutaneous fat
necrosis with characteristic rash and hypercalcaemia. Arch Dis Child Fetal
Neonatal Ed. 2007;92(4):F304.
21. Tran JT, Sheth AP. Complications of subcutaneous fat necrosis of the
newborn: a case report and review of the literature. Pediatr Dermatol.
2003;20(3):257–61.
22. Wiadrowski TP, Marshman G. Subcutaneous fat necrosis of the newborn
following hypothermia and complicated by pain and hypercalcemia.
Australas J Dermatol. 2001;42(3):207–10.
23. Duhn R, Schoen EJ, Siu M. Subcutaneous fat necrosis with extensive
calcification after hypothermia in two newborn infants. Pediatrics.
1968;41(3):661–4.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Grass et al. BMC Pediatrics  (2015) 15:73 Page 7 of 7
